Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

COREG Drug Profile

« Back to Dashboard

Which patents cover Coreg, and what generic Coreg alternatives are available?

Coreg is a drug marketed by Smithkline Beecham and is included in two NDAs. There are two patents protecting this drug and three Paragraph IV challenges.

The generic ingredient in COREG is carvedilol phosphate. There are thirty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the carvedilol phosphate profile page.

Summary for Tradename: COREG

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list3
Bulk Api Vendors: see list81
Clinical Trials: see list13
Patent Applications: see list4,818
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:COREG at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-004May 29, 1997ABRXYesNo► Subscribe► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-002Oct 20, 2006RXYesNo7,268,156*PED► SubscribeY► Subscribe
Smithkline Beecham
COREG
carvedilol
TABLET;ORAL020297-001Sep 14, 1995ABRXYesNo► Subscribe► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-004Oct 20, 2006RXYesNo8,101,209*PED► SubscribeY► Subscribe
Smithkline Beecham
COREG CR
carvedilol phosphate
CAPSULE, EXTENDED RELEASE;ORAL022012-002Oct 20, 2006RXYesNo8,101,209*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot